RE-BVS – Piemonte Repository

Sfoglia per AUTORE
DZIADZIUSZKO R
Collezione AOU San Luigi di Orbassano

Items : 6

Atezolizumab versus chemotherapy in advanced or metastatic NSCLC with high blood-based tumor mutational burden: primary analysis of BFAST cohort C randomized phase 3 trial. in Nature medicine / Nat Med. 2022 Sep;28(9):1831-1839. doi: 10.1038/s41591-022-01933-w. Epub 2022 Aug 22.

2022
AOU San Luigi di Orbassano

Peters S; Dziadziuszko R; Morabito A; Felip E; Gadgeel SM; Cheema P; Cobo M; Andric Z; Barrios CH; Yamaguchi M; Dansin E; Danchaivijitr P; Johnson M; Novello S; Mathisen MS; Shagan SM; Schleifman E; Wang J; Yan M; Mocci S; Voong D; Fabrizio DA; Shames DS; Riehl T; Gandara DR; Mok T;

Results of screening in early and advanced thoracic malignancies in the EORTC pan-European SPECTAlung platform. in Scientific reports / Sci Rep. 2022 May 18;12(1):8342. doi: 10.1038/s41598-022-12056-0.

2022
AOU San Luigi di Orbassano

Morfouace M; Novello S; Stevovic A; Dooms C; Janži? U; Berghmans T; Dziadziuszko R; Gorlia T; Felip E; Paz-Ares L; Mazieres J; O'Brien M; Bironzo P; Vansteenkiste J; Lacroix L; Dingemans AC; Golfinopoulos V; Besse B;

Liquid Biopsy for Advanced NSCLC: A Consensus Statement From the International Association for the Study of Lung Cancer. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2021 Oct;16(10):1647-1662. doi: 10.1016/j.jtho.2021.06.017. Epub 2021 Jul 8.

2021
AOU San Luigi di Orbassano

Rolfo C; Mack P; Scagliotti GV; Aggarwal C; Arcila ME; Barlesi F; Bivona T; Diehn M; Dive C; Dziadziuszko R; Leighl N; Malapelle U; Mok T; Peled N; Raez LE; Sequist L; Sholl L; Swanton C; Abbosh C; Tan D; Wakelee H; Wistuba I; Bunn R; Freeman-Daily J; Wynes M; Belani C; Mitsudomi T; Gandara D;

Afatinib in EGFR TKI-naïve patients with locally advanced or metastatic EGFR mutation-positive non-small cell lung cancer: Interim analysis of a Phase 3b study. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2021 Feb;152:127-134. doi: 10.1016/j.lungcan.2020.12.011. Epub 2020 Dec 17.

2021
AOU San Luigi di Orbassano

de Marinis F; Laktionov KK; Poltoratskiy A; Egorova I; Hochmair M; Passaro A; Migliorino MR; Metro G; Gottfried M; Tsoi D; Ostoros G; Rizzato S; Mukhametshina GZ; Schumacher M; Novello S; Dziadziuszko R; Tang W; Clementi L; Cseh A; Kowalski D; de Marinis F; Laktionov KK; Poltoratskiy A; Egorova I; Hochmair M; Passaro A; Migliorino MR; Metro G; Gottfried M; et alii...

Definition of Synchronous Oligometastatic Non-Small Cell Lung Cancer-A Consensus Report. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2019 Dec;14(12):2109-2119. doi: 10.1016/j.jtho.2019.07.025. Epub 2019 Aug 6.

2019
AOU San Luigi di Orbassano

Dingemans AC; Hendriks LEL; Berghmans T; Levy A; Hasan B; Faivre-Finn C; Giaj-Levra M; Giaj-Levra N; Girard N; Greillier L; Lantuéjoul S; Edwards J; O'Brien M; Reck M; Smit EF; Van Schil P; Postmus PE; Ramella S; Lievens Y; Gaga M; Peled N; Scagliotti GV; Senan S; Paz-Ares L; Guckenberger M; McDonald F; Ekman S; Cufer T; Gietema H; et alii...

The APPLE Trial: Feasibility and Activity of AZD9291 (Osimertinib) Treatment on Positive PLasma T790M in EGFR-mutant NSCLC Patients. EORTC 1613. in Clinical lung cancer / Clin Lung Cancer. 2017 Sep;18(5):583-588. doi: 10.1016/j.cllc.2017.02.005. Epub 2017 Mar 1.

2017
AOU San Luigi di Orbassano

Remon J; Menis J; Hasan B; Peric A; De Maio E; Novello S; Reck M; Berghmans T; Wasag B; Besse B; Dziadziuszko R;